Genomize
Healthcare Software · 11-50 Employees
View Company Info for Free
Overview
Website
www.genomize.comRevenue
<$5 MillionIndustry
About Genomize
Genomize Org Chart
Is Genomize your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Genomize
Funding: Get notified immidiatlly once Genomize has new funding data
Check if Genomize has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Genomize had a recent Job posting/layoffs
Product Launch: Get notified when Genomize launches new products
Genomize, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Genomize recently announced quarterly report
Check out if Genomize is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Genomize as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Genomize is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Genomize is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Genomize.
Genomize Tech Stack
A closer look at the technologies used by Genomize
Genomize News & Media
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genomize
Genomize specializes in transforming genomic data into actionable insights through its SEQ Platform, which offers comprehensive NGS data analysis and accurate ACMG classification for variant interpretation. Their products include the SEQ Platform, Covid19-qPCR, and a Pathogenicity Calculator, aimed at enhancing diagnostic accuracy and supporting cl... Read More